Natec Medical is now able to market Tamarin Blue and Filao RX in Canada

15th April 2013

244

Natec Medical has announced that in March, it received a license to market its Tamarin Blue and Filao RX in Canada.

According to a company press release, Tamarin Blue, FDA approved and CE marked, is the “ultimate platform” for all current and future stent and drug-coated technologies. Filao RX (CE marked) is the company’s percutaneous transluminal coronary angioplasty balloon catheter for angioplasty and predilatation